10% Discount on Personalized Medicine Market Report (Valid till 30th Sept 2016)

Medicine-Market-Report

Bharatbook.com announces a report on “Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2019 – Strategic Analysis of Industry Trends, Technologies, Participants, and Environment”. Key strengths, weaknesses and threats influencing leading player position within the market.

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by over 360 tables & figures over 393 pages. The Personalized Medicine (global & USA) market is presented as follows:

  • By Company (e.g., Qiagen, AFFYMETRIX, ATOSSA GENETICS, NODALITY, deCode /Amgen, CELERA, MYRIAD)
  • By Segment (Targeted therapeutics, Companion Diagnostics, Liquid Biopsies)
  • By Sub-market (Companion diagnostic, targeted cancer therapeutic, medical technology, pharmacogenomics, consumer genomics, molecular diagnostics, liquid biopsy) • By Therapy (Cancer, Cardiovascular, Infectious Disease)

Key Opinion Leaders that contributed to interview questions within the report include:

  • Iain D. Miller, PhD, MBA, Founder & CEO, Healthcare Strategies Group
  • Stephen Finn, MBBS, PhD, Associate Professor, Cancer Molecular Diagnostic Laboratory, Consultant Histopathologist and Head of Histopathology, St James’s Hospital and Trinity College Dublin, Ireland
  • Ronald Przygodzki, MD, Director, Genomic Medicine Implementation at U.S. Department of Veterans Affairs, Washington DC
  • Elaine Kenny, PhD, Founder, Elda Biotech, Dublin 2, Ireland
  • Chad Clark, Co-President and Chief Operating Officer, Precision for Medicine
  • Tobias Guennel, PhD, Principal, Biomarker and IVD Analytics, Precision for Medicine
  • David Parker, PhD, Vice President, Integrated Market Access, Precision for Medicine
  • Deborah Phippard, PhD, Vice President, Research, Precision for Medicine
  • Judi Smith, MS, Vice President, In Vitro Diagnostics Regulatory and Quality, Precision for Medicine

 

A wealth of financial data & business strategy information is provided including:

 

  • Company financials, sales & revenue figures
  • Business Model Strategies for Diagnostic, Pharmaceutical and Biotechnology Companies
  • Business Model Strategies for Providers. Provider Systems and Academic Medical Centres
  • Business Model Strategies for Payers & Governments
  • Private and Public Funding and Personalized Medicine Reimbursement
  • Revisions to Current Payment Systems and intellectual property
  • How to Gain Market Penetration in the EU
  • Cost-effectiveness and Business Value of Personalized Medicine
  • Therapeutics and Companion Diagnostics (e.g., BRAC Analysis, Oncotype Dx , KRAS Mutations)
  • Comprehensive account of company product portfolios & kits

 

SWOT, Economic & Regulatory Environment specifics include:

 

  • Key strengths, weaknesses and threats influencing leading player position within the market
  • Technologies driving the market (e.g., New-Generation Sequencing Technologies, Ultra-High Throughput Sequencing)
  • Top fastest growing market segments and emerging opportunities
  • Top pharmaceutical companies within the IPM by market share and revenue
  • Comprehensive product portfolios, R&D activity and pipeline therapeutics
  • M&A activity and future strategies of top personalized medicine pharmacos
  • Personalized Medicine Regulation (USA, UK, Germany, France, Spain, Italy)
  • CE-marked Personalized Medicine/Diagnostic Tests
  • FDA Advances in Personalized Medicine Regulation

Related Reports: Healthcare Market Research Reports

Contact us at:

Bharat Book Bureau

Tel: +91 22 27810772 / 27810773

Email : poonam@bharatbook.com

Website : www.bharatbook.com